Bioage Labs Inc 's Revenue in the fiscal year 2025 $ 9.00 millions
Bioage Labs Inc 's Revenue in the fiscal year 2024 $ 0.00 millions
Bioage Labs Inc 's Revenue in the fiscal year 2017 $ 14.94 millions
Bioage Labs Inc 's Revenue in the fiscal year 2016 $ 8.27 millions
Bioage Labs Inc 's Revenue in the fiscal year 2015 $ 2.17 millions
BIOA Revenue second quarter 2026 Y/Y Growth Comment
Bioage Labs Inc reported Revenue growth of 1.7% year on year in the second quarter 2026, to $ 2.45 millions, this is lower than Bioage Labs Inc 's recent average Revenue rise of 84.63%.
Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 72 other companies have achieved higher Revenue growth. While Bioage Labs Inc ' s Revenue increase of 1.7% ranks overall at the positon no. 1130 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Bioage Labs Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
236.28 %
33.11 %
-82.75 %
(Mar 31 2017)
BIOA's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Bioage Labs Inc disclosed drop in Revenue from the first quarter by -11.52% to $ 2.45 millions, from $ 2.77 millions achived in the previous reporting period.
Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Major Pharmaceutical Preparations's company achievement, Most analysts pointed out.
Within Major Pharmaceutical Preparations industry 131 other companies have achieved higher Revenue quarter on quarter growth. While Bioage Labs Inc 's Revenue growth quarter on quarter, overall rank is 2956.
In the II. Quarter 2026 Bioage Labs Inc disclosed drop in Revenue from the first quarter by -11.52% to $ 2.45 millions, from $ 2.77 millions achived in the previous reporting period.
Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Major Pharmaceutical Preparations's company achievement, Most analysts pointed out.
Within Major Pharmaceutical Preparations industry 131 other companies have achieved higher Revenue quarter on quarter growth. While Bioage Labs Inc 's Revenue growth quarter on quarter, overall rank is 2956.
Bioage Labs Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 10.36
$ 10.32
$ 9.00
$ 0.00
$ 0.00
Y / Y Revenue Growth (TTM)
-
-
-
-
-
Year on Year Revenue Growth Overall
Ranking
#
#
#
#
#
Seqeuential Revenue Change (TTM)
0.38 %
14.69 %
-
-
-
Seq. Revenue Growth (TTM) Overall
Ranking
# 1135
# 676
# 0
# 0
# 83
Cumulative Revenue growth Comment
Bioage Labs Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 1.7% year on year, to $ 10 millions if the fiscal year would have ended in Jun 30 2026. Bioage Labs Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Bioage Labs Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry. But from twelve months ended Mar 31 2026 rise was beneth at 0.38 % from $10.32 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at84.63%.
Bioage Labs Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
Bioage Labs Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 1.7% year on year, to $ 10 millions if the fiscal year would have ended in Jun 30 2026. Bioage Labs Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Bioage Labs Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry. But from twelve months ended Mar 31 2026 rise was beneth at 0.38 % from $10.32 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at84.63%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 0.38 % increase from $10.32 millions in the period from Mar 31 2026 to Jun 30 2025.
Bioage Labs Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
About Bioage Labs Inc Revenue Growth Rates (BIOA), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
2.79%